Zante Greg Insider Trades

Insider Trading History

Track insider trading activity for Zante Greg. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Viking Therapeutics
Viking Therapeutics VKTX
Chief Financial Officer
Holding Value $7.18M 189,891 shares
Last Trade
Jan 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$48.1k 1,500 shares
$32.09
$37.81
Viking Therapeutics
Viking Therapeutics VKTX
Chief Financial Officer
Holding Value $7.63M 201,671 shares
Last Trade
Jan 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$464k 13,900 shares
$33.38
$37.81
Viking Therapeutics
Viking Therapeutics VKTX
Chief Financial Officer
Holding Value $7.24M 191,371 shares
Last Trade
Jan 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$353k 10,300 shares
$34.24
$37.81
Viking Therapeutics
Viking Therapeutics VKTX
Chief Financial Officer
Holding Value $8.15M 215,571 shares
Last Trade
Jan 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.03M 31,961 shares
$32.30
$37.81
Viking Therapeutics
Viking Therapeutics VKTX
Chief Financial Officer
Holding Value $8.15M 215,483 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.45M 41,000 shares
$35.42
$37.81
Viking Therapeutics
Viking Therapeutics VKTX
Chief Financial Officer
Holding Value $3.44M 91,000 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.22M 91,000 shares
$35.42
$37.81
Viking Therapeutics
Viking Therapeutics VKTX
Chief Financial Officer
Holding Value $9.36M 247,532 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.14M 32,049 shares
$35.42
$37.81
Viking Therapeutics
Viking Therapeutics VKTX
Chief Financial Officer
Holding Value $6.56M 173,592 shares
Last Trade
Oct 28, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$216k 6,185 shares
$35.00
$37.81
Viking Therapeutics
Viking Therapeutics VKTX
Chief Financial Officer
Holding Value $6.8M 179,777 shares
Last Trade
Oct 27, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$399k 11,117 shares
$35.93
$37.81
Viking Therapeutics
Viking Therapeutics VKTX
Chief Financial Officer
Holding Value $6.38M 168,660 shares
Last Trade
Jul 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$118k 4,266 shares
$27.76
$37.81
Viking Therapeutics
Viking Therapeutics VKTX
Chief Financial Officer
Holding Value $6.54M 172,926 shares
Last Trade
Jul 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$213k 7,667 shares
$27.72
$37.81
Viking Therapeutics
Viking Therapeutics VKTX
Chief Financial Officer
Holding Value $6.43M 169,959 shares
Last Trade
Jan 06, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.15M 50,309 shares
$42.75
$37.81
Viking Therapeutics
Viking Therapeutics VKTX
Chief Financial Officer
Holding Value $8.15M 215,568 shares
Last Trade
Jan 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.6M 37,200 shares
$42.89
$37.81
Viking Therapeutics
Viking Therapeutics VKTX
Chief Financial Officer
Holding Value $10.6M 281,053 shares
Last Trade
Oct 28, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7M 94,001 shares
$74.52
$37.81
Viking Therapeutics
Viking Therapeutics VKTX
Chief Financial Officer
Holding Value $5.78M 153,000 shares
Last Trade
Oct 28, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7M 94,001 shares
$74.52
$37.81
Viking Therapeutics
Viking Therapeutics VKTX
Chief Financial Officer
Holding Value $8.75M 231,381 shares
Last Trade
Oct 28, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$10.1M 131,687 shares
$76.62
$37.81
Viking Therapeutics
Viking Therapeutics VKTX
Chief Financial Officer
Holding Value $7.2M 190,526 shares
Last Trade
Jul 30, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$922k 16,136 shares
$57.15
$37.81
Viking Therapeutics
Viking Therapeutics VKTX
Chief Financial Officer
Holding Value $9.14M 241,610 shares
Last Trade
May 03, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.64M 34,249 shares
$76.97
$37.81
Viking Therapeutics
Viking Therapeutics VKTX
Chief Financial Officer
Holding Value $2.27M 60,000 shares
Last Trade
May 03, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.64M 34,249 shares
$76.97
$37.81
Viking Therapeutics
Viking Therapeutics VKTX
Chief Financial Officer
Holding Value $9.02M 238,509 shares
Last Trade
May 03, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.99M 66,756 shares
$74.69
$37.81

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up